USFDA lifts clinical hold on Opella’s planned actual use trial to switch Cialis from prescription to OTC Read more
Zydus receives USFDA approval to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with ALS Read more